US2013035286A1PendingUtilityA1
Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues
Est. expiryJun 24, 2023(expired)· nominal 20-yr term from priority
A61P 9/00A61P 3/04A61P 9/10A61P 5/04A61P 3/08A61P 37/06A61P 5/48A61P 5/08A61P 5/46A61P 29/00A61P 3/10A61P 35/02A61P 27/02A61P 35/00A61P 25/02A61P 1/18A61P 13/12A61P 17/06A61P 1/00A61P 1/12A61P 19/02A61K 38/31C07K 7/06C07K 14/6555C07K 14/655
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention describes parenteral pharmaceutical compositions comprising a somatostatin analogue and novel somatostatin analogues.
Claims
exact text as granted — not AI-modified1 . A liquid formulation for parenteral administration buffered at a pH of about 4 to about 4.5 and comprising as active ingredient cyclo[{4-(NH 2 —C 2 H 4 —NH—CO—O-)Pro}-Phg-DTrp-Lys-Tyr(4-Bzl)-Phe] or a pharmaceutically acceptable salt thereof.
2 . A liquid formulation according to claim 1 wherein the composition is buffered by an acetate/acetic acid, lactate/lactic acid, or Glycin/HCl buffer.Join the waitlist — get patent alerts
Track US2013035286A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.